Similar articles

• Managing tuberculosis in people who use and inject illicit drugs.

  Getahun H, Baddeley A, Raviglione M. Getahun H, et al. Bull World Health Organ. 2013 Feb 1;91(2):154-6. doi: 10.2471/BLT.13.117267. Bull World Health Organ. 2013. PMID: 23554532 Free PMC article. No abstract available.
• Implementation of rapid HIV and HCV testing within harm reduction programmes for people who inject drugs: a pilot study.

  Fernàndez-López L, Folch C, Majó X, Gasulla L, Casabona J. Fernàndez-López L, et al. AIDS Care. 2016;28(6):712-6. doi: 10.1080/09540121.2016.1164290. Epub 2016 Mar 23. AIDS Care. 2016. PMID: 27007000
• HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice.

  Stöver H, Dichtl A, Schäffer D, Grabski M. Stöver H, et al. Harm Reduct J. 2023 Apr 13;20(1):50. doi: 10.1186/s12954-023-00774-1. Harm Reduct J. 2023. PMID: 37055763 Free PMC article. Review.
• Science versus politics: the need for supervised injection facilities in Montreal, Canada.

  Jozaghi E. Jozaghi E. Int J Drug Policy. 2012 Sep;23(5):420-1. doi: 10.1016/j.drugpo.2012.06.003. Epub 2012 Jul 18. Int J Drug Policy. 2012. PMID: 22818890 No abstract available.
• [Illegal drug users and risk factors for HIV and HCV infection].

  Backmund M. Backmund M. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 Apr;50(4):471-5. doi: 10.1007/s00103-007-0189-7. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007. PMID: 17377722 Review. German.